SINDHU CHERIAN, MD
Medical Practice at Pacific St, Seattle, WA

License number
Washington MD00044864
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
License number
Washington MD00044864
Category
Medical Practice
Type
Hematology
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 598-6131
(206) 543-6420

Personal information

See more information about SINDHU CHERIAN at radaris.com
Name
Address
Phone
Sindhu Cherian
3249 56Th St, Seattle, WA 98107
(206) 729-1035
Sindhu Cherian
6022 Latona Ave NE, Seattle, WA 98115
(206) 729-1035
Sindhu J Cherian
5217 305Th St, Auburn, WA 98001

Professional information

See more information about SINDHU CHERIAN at trustoria.com
Sindhu Cherian Photo 1
Dr. Sindhu Cherian, Seattle WA - MD (Doctor of Medicine)

Dr. Sindhu Cherian, Seattle WA - MD (Doctor of Medicine)

Specialties:
Hematology, Hematopathology
Age:
49
Address:
1959 NE Pacific St, Seattle 98195
(206) 598-6131 (Phone)
Seattle
1959 NE Pacific St, Seattle 98195
(206) 598-3300 (Phone)
Certifications:
Clinical Pathology, 2004, Hematology & Pathology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1959 NE Pacific St, Seattle 98195
Seattle
1959 NE Pacific St, Seattle 98195
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
Emory Univ Sch Of Med
Graduated: 2000


Sindhu Cherian Photo 2
Sindhu Cherian, Seattle WA

Sindhu Cherian, Seattle WA

Specialties:
Pathologist
Address:
1959 Ne Pacific St, Seattle, WA 98195
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology), American Board of Pathology Sub-certificate in Hematology (Pathology)


Sindhu Cherian Photo 3
Method For Diagnosis Of Myelodysplastic Syndromes (Mds)

Method For Diagnosis Of Myelodysplastic Syndromes (Mds)

US Patent:
2008002, Jan 31, 2008
Filed:
Nov 7, 2005
Appl. No.:
11/667406
Inventors:
Jonni Moore - Moorestown NJ, US
Sindhu Cherian - Seattle WA, US
Adam Bagg - Gulph Mills PA, US
International Classification:
G01N 33/567
US Classification:
435007200
Abstract:
The present invention provides a method of diagnosing a mylodysplastic syndrome, a method of ascertaining the clinical course of a myelodysplastic syndrome or a method of ascertaining response to a therapy regimen in a subject diagnosed with a myelodysplastic syndrome, and kits for effecting the same.


Sindhu Cherian Photo 4
Methods For Diagnosis Of Myelodysplastic Syndromes (Mds)

Methods For Diagnosis Of Myelodysplastic Syndromes (Mds)

US Patent:
2013019, Aug 1, 2013
Filed:
Jan 11, 2013
Appl. No.:
13/739250
Inventors:
The Trustees of the University of Pennsylvania - Philadelphia PA, US
Sindhu Cherian - Seattle WA, US
Adam Bagg - Gulph Mills PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
G01N 33/50
US Classification:
435 721, 435 29
Abstract:
The present invention relates to methods and kits for diagnosing, ascertaining the clinical course of myelodysplastic syndrome (MDS) and ascertaining response to a therapy regimen of myelodysplastic syndrome. Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with MDS based on surface markers unique to MDS.


Sindhu Cherian Photo 5
Methods For Diagnosis Of Myelodysplastic Syndromes (Mds)

Methods For Diagnosis Of Myelodysplastic Syndromes (Mds)

US Patent:
8377649, Feb 19, 2013
Filed:
Feb 1, 2011
Appl. No.:
13/019167
Inventors:
Jonni Moore - Moorestown NJ, US
Sindhu Cherian - Seattle WA, US
Adam Bagg - Gulph Mills PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61K 49/00, G01N 33/574
US Classification:
435 723, 435 72, 435 724, 4352872, 435973, 424 92, 436 10, 436 63, 436 64, 436164, 436172, 436811, 436813, 422 73, 422 8208, 422 8209
Abstract:
The present invention relates to methods and kits for diagnosing, ascertaining the clinical course of myelodysplastic syndrome (MDS) and ascertaining response to a therapy regimen of myelodysplastic syndrome. Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with MDS based on surface markers unique to MDS.